Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama

Detalhes bibliográficos
Autor(a) principal: Silva, Lucas Eduardo Correia da
Data de Publicação: 2019
Tipo de documento: Trabalho de conclusão de curso
Idioma: por
Título da fonte: Repositório Institucional da UFU
Texto Completo: https://repositorio.ufu.br/handle/123456789/28520
Resumo: Introduction: Breast cancer is one of the leading causes of death worldwide, being more frequent in women. It can be classified by hormone receptors, staging, grade, molecular subtype, metastasis and among other variables. Generally speaking, cytokines involve a large group of molecules that are capable of evoking effects on cells in an immune response and many of them are involved in tumor development, whether anti or pro-tumor. TNF-α and IL-6 have their dichotomous role shown in several studies, since both are proinflammatory cytokines and their primary function is to maintain the body's homeostasis, but they may assume a pro-tumoral role depending factors such as: tumor type, tumor microenvironment, interference of other cytokines, deregulation in its production, among others. Therefore, establishing a relationship between these cytokines and some clinical factors of patients may provide important information to analyze the tumor biomarker potential of these cytokines. Objective: This study aimed to quantify IL-6 and TNF-afa in the serum of breast cancer patients and to analyze their relationship with some clinical variables. Methodology: Flow cytometry was used with LegendPlex, a kit based on sandwich immunoassay principles to detect and quantify these cytokines in the serum of 80 breast cancer patients. Results: The results obtained show that there is no relationship between TNF-alpha and IL-6 cytokines with clinical variables. Conclusion: It was concluded that there is no significant relationship between the analyzed cytokines and the clinical variables.
id UFU_2f0186f4a7c6c1b8859d0efe28ff0db0
oai_identifier_str oai:repositorio.ufu.br:123456789/28520
network_acronym_str UFU
network_name_str Repositório Institucional da UFU
repository_id_str
spelling Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mamaCâncer de mamaCitocinasIL-6TNF-alfaLegendPlexReceptores hormonaisSubtipo molecularEstadiamento tumoralGrau tumoralBreast cancerCytokinesHormone receptorsMolecular subtypeTumor stagingTumor gradeCNPQ::CIENCIAS DA SAUDEIntroduction: Breast cancer is one of the leading causes of death worldwide, being more frequent in women. It can be classified by hormone receptors, staging, grade, molecular subtype, metastasis and among other variables. Generally speaking, cytokines involve a large group of molecules that are capable of evoking effects on cells in an immune response and many of them are involved in tumor development, whether anti or pro-tumor. TNF-α and IL-6 have their dichotomous role shown in several studies, since both are proinflammatory cytokines and their primary function is to maintain the body's homeostasis, but they may assume a pro-tumoral role depending factors such as: tumor type, tumor microenvironment, interference of other cytokines, deregulation in its production, among others. Therefore, establishing a relationship between these cytokines and some clinical factors of patients may provide important information to analyze the tumor biomarker potential of these cytokines. Objective: This study aimed to quantify IL-6 and TNF-afa in the serum of breast cancer patients and to analyze their relationship with some clinical variables. Methodology: Flow cytometry was used with LegendPlex, a kit based on sandwich immunoassay principles to detect and quantify these cytokines in the serum of 80 breast cancer patients. Results: The results obtained show that there is no relationship between TNF-alpha and IL-6 cytokines with clinical variables. Conclusion: It was concluded that there is no significant relationship between the analyzed cytokines and the clinical variables.Trabalho de Conclusão de Curso (Graduação)Introdução: O câncer de mama é uma das principais causas de morte no mundo, sendo mais frequente nas mulheres. Ele pode ser classificado pelos receptores hormonais, estadiamento, grau, subtipo molecular, metástase e dentre outras variáveis. De um modo geral, as citocinas envolvem um vasto grupo de moléculas que são capazes de evocar efeitos nas células em uma resposta imune e muitas delas estão envolvidas no desenvolvimento do tumor, sendo anti ou pró-tumoral. O TNF-α e a IL-6 têm seu papel dicotômico mostrado em diversos estudos, pois as duas são citocinas pró-inflamatórias e tem como função primordial manter a homeostase do organismo, porém, elas podem assumir um papel pró-tumoral dependendo de uma série de fatores como: tipo do tumor, microambiente tumoral, interferência de outras citocinas, desregulação na sua produção, entre outros. Portanto, estabelecer uma relação entre essas citocinas e alguns fatores clínicos dos pacientes pode fornecer informações importantes para analisar o potencial de biomarcador tumoral dessas citocinas. Objetivo: Esse trabalho teve como objetivo quantificar IL-6 e TNF-afa no soro de pacientes com câncer de mama e analisar sua relação com algumas variáveis clínicas. Metodologia: Foi utilizado a citometria de fluxo com o LegendPlex, um kit que se baseia nos princípios de imunoensaio sanduíche para detectar e quantificar essas citocinas no soro de 80 pacientes com câncer de mama. Resultados: Os resultados obtidos mostram que não há relação entre as citocinas TNF-alfa e IL-6 com as variáveis clínicas. Conclusão: Concluiu-se que não existe uma relação significativa entre as citocinas analisadas e as variáveis clínicas.Universidade Federal de UberlândiaBrasilBiomedicinaSilva, Marcelo José Barbosahttp://lattes.cnpq.br/1896030259489819Botelho, Françoise Vasconceloshttp://lattes.cnpq.br/0523032311499606Borges, Bruna Cristinahttp://lattes.cnpq.br/1239727610132040Silva, Lucas Eduardo Correia da2020-01-27T12:51:51Z2020-01-27T12:51:51Z2019-12-10info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bachelorThesisapplication/pdfSILVA, Lucas Eduardo Correia da. Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama. 2019. 31 f. Trabalho de Conclusão de Curso (Graduação em Biomedicina) – Universidade Federal de Uberlândia, Uberlândia, 2020.https://repositorio.ufu.br/handle/123456789/28520porinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFUinstname:Universidade Federal de Uberlândia (UFU)instacron:UFU2020-01-28T06:13:00Zoai:repositorio.ufu.br:123456789/28520Repositório InstitucionalONGhttp://repositorio.ufu.br/oai/requestdiinf@dirbi.ufu.bropendoar:2020-01-28T06:13Repositório Institucional da UFU - Universidade Federal de Uberlândia (UFU)false
dc.title.none.fl_str_mv Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama
title Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama
spellingShingle Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama
Silva, Lucas Eduardo Correia da
Câncer de mama
Citocinas
IL-6
TNF-alfa
LegendPlex
Receptores hormonais
Subtipo molecular
Estadiamento tumoral
Grau tumoral
Breast cancer
Cytokines
Hormone receptors
Molecular subtype
Tumor staging
Tumor grade
CNPQ::CIENCIAS DA SAUDE
title_short Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama
title_full Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama
title_fullStr Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama
title_full_unstemmed Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama
title_sort Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama
author Silva, Lucas Eduardo Correia da
author_facet Silva, Lucas Eduardo Correia da
author_role author
dc.contributor.none.fl_str_mv Silva, Marcelo José Barbosa
http://lattes.cnpq.br/1896030259489819
Botelho, Françoise Vasconcelos
http://lattes.cnpq.br/0523032311499606
Borges, Bruna Cristina
http://lattes.cnpq.br/1239727610132040
dc.contributor.author.fl_str_mv Silva, Lucas Eduardo Correia da
dc.subject.por.fl_str_mv Câncer de mama
Citocinas
IL-6
TNF-alfa
LegendPlex
Receptores hormonais
Subtipo molecular
Estadiamento tumoral
Grau tumoral
Breast cancer
Cytokines
Hormone receptors
Molecular subtype
Tumor staging
Tumor grade
CNPQ::CIENCIAS DA SAUDE
topic Câncer de mama
Citocinas
IL-6
TNF-alfa
LegendPlex
Receptores hormonais
Subtipo molecular
Estadiamento tumoral
Grau tumoral
Breast cancer
Cytokines
Hormone receptors
Molecular subtype
Tumor staging
Tumor grade
CNPQ::CIENCIAS DA SAUDE
description Introduction: Breast cancer is one of the leading causes of death worldwide, being more frequent in women. It can be classified by hormone receptors, staging, grade, molecular subtype, metastasis and among other variables. Generally speaking, cytokines involve a large group of molecules that are capable of evoking effects on cells in an immune response and many of them are involved in tumor development, whether anti or pro-tumor. TNF-α and IL-6 have their dichotomous role shown in several studies, since both are proinflammatory cytokines and their primary function is to maintain the body's homeostasis, but they may assume a pro-tumoral role depending factors such as: tumor type, tumor microenvironment, interference of other cytokines, deregulation in its production, among others. Therefore, establishing a relationship between these cytokines and some clinical factors of patients may provide important information to analyze the tumor biomarker potential of these cytokines. Objective: This study aimed to quantify IL-6 and TNF-afa in the serum of breast cancer patients and to analyze their relationship with some clinical variables. Methodology: Flow cytometry was used with LegendPlex, a kit based on sandwich immunoassay principles to detect and quantify these cytokines in the serum of 80 breast cancer patients. Results: The results obtained show that there is no relationship between TNF-alpha and IL-6 cytokines with clinical variables. Conclusion: It was concluded that there is no significant relationship between the analyzed cytokines and the clinical variables.
publishDate 2019
dc.date.none.fl_str_mv 2019-12-10
2020-01-27T12:51:51Z
2020-01-27T12:51:51Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/bachelorThesis
format bachelorThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv SILVA, Lucas Eduardo Correia da. Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama. 2019. 31 f. Trabalho de Conclusão de Curso (Graduação em Biomedicina) – Universidade Federal de Uberlândia, Uberlândia, 2020.
https://repositorio.ufu.br/handle/123456789/28520
identifier_str_mv SILVA, Lucas Eduardo Correia da. Avaliação das citocinas IL-6 e TNF-alfa no soro de pacientes com câncer de mama. 2019. 31 f. Trabalho de Conclusão de Curso (Graduação em Biomedicina) – Universidade Federal de Uberlândia, Uberlândia, 2020.
url https://repositorio.ufu.br/handle/123456789/28520
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Uberlândia
Brasil
Biomedicina
publisher.none.fl_str_mv Universidade Federal de Uberlândia
Brasil
Biomedicina
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFU
instname:Universidade Federal de Uberlândia (UFU)
instacron:UFU
instname_str Universidade Federal de Uberlândia (UFU)
instacron_str UFU
institution UFU
reponame_str Repositório Institucional da UFU
collection Repositório Institucional da UFU
repository.name.fl_str_mv Repositório Institucional da UFU - Universidade Federal de Uberlândia (UFU)
repository.mail.fl_str_mv diinf@dirbi.ufu.br
_version_ 1813711368305508352